Historical daily share price chart and data for Landos Biopharma, Inc. from to adjusted for splits and dividends. LABP was delisted after May Landos Biopharma (LABP) raised $ million in an initial public offering on Thursday, February 4th The company issued 6,, shares at a price of. Landos Biopharma Inc is listed in the sector of the NASDAQ with ticker LABP. The last closing price for Landos Biopharma was $ Over the last year. Landos Biopharma Inc. ; Next Fiscal Year Estimate, ; Median PE on Next FY Estimate, N/A ; High, $ ; Median, $ ; Low, $ Looking to buy Landos Biopharma Stock? View today's LABP stock price, trade commission-free, and discuss LABP stock updates with the investor community.
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of novel, oral, once-daily therapeutics for patients with. LABP Landos Biopharma · High. · Low. · Volume. 0 · Open. · Pre Close. · Turnover. · Turnover Ratio. % · P/E (Static). Loss. Landos Biopharma, Inc. Stock. Equities. LABP. US Biotechnology & Medical Research. Market Closed - Nasdaq. According to Landos Biopharma, Inc.'s latest financial reports and current stock price. The company's current Enterprise Value is M. This represents a. News for Landos Biopharma Stock (LABP) · AbbVie Completes Acquisition of Landos Biopharma · LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of. LABP Stock Overview ; Landos Biopharma Files Form Jun 04 ; Landos Biopharma, Inc. Announces Board and Executive Changes. May 25 ; Landos Biopharma, Inc.. In the current month, LABP has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. LABP average Analyst price target in the past 3 months is $ Free LANDOS BIOPHARMA INC COM NEW CVR (happygamestation.ru) analysis tools, including analyst ratings and target price forecasts, help you make informed investment. Institutional Ownership and Shareholders. Landos Biopharma, Inc. (US:LABP) has 13 institutional owners and shareholders that have filed 13D/G or 13F forms with. Landos Biopharma Quote Info ; Trades, 0 ; 52 Week Range, - ; Volume, 0 ; Avg Volume, - ; Currency, USD.
Get Landos Biopharma Inc (LABP) share price, real-time stock quotes, historical charts and financial information. Start Investing in Landos Biopharma Inc. Landos Biopharma (LABP) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Landos Biopharma, Inc. (happygamestation.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Landos Biopharma, Inc. | Nasdaq. Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with. Landos Biopharma is a clinical stage biopharmaceutical company focused on Stock Information. NASDAQ GS: LABP. $ High $ Change + View. View LANDOS BIOPHARMA INC COM NEW CVR (happygamestation.ru) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. The week high for Landos Biopharma, Inc. Stock is $ and the week low is $ As of the Aug 22, , the market capitalization of Landos Biopharma. You can watch LABP and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling. Track Landos Biopharma Inc (LABP) Stock Price, Quote, latest community messages, chart, news and other stock related information.
The average one-year price target for Landos Biopharma, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. LABP Landos Biopharma Inc. $ $ (%). Today. Watchers, Wk Low, $ Wk High, $ Market Cap, $M. Volume, 50, Landos Biopharma Inc (LABP) · Volume: 0 · Bid/Ask: / · Day's Range: - Webull offers Landos Biopharma, Inc. LABP historical stock prices, in-depth market analysis,NASDAQ:LABP real-time stock quote data, in-depth charts. Get Landos Biopharma, Inc. (LABP) real-time share value, investment, rating and financial market information from Capital.
MOMENTUM IS EXPANDING : LABP STOCK ANALYSIS - LANDOS BIOPHARMA STOCK